ME
McIlrath & Eck’s AstraZeneca AZN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.26K | Hold |
61
| – | – | ﹤0.01% | 745 |
|
2025
Q1 | $4.48K | Hold |
61
| – | – | ﹤0.01% | 738 |
|
2024
Q4 | $4K | Hold |
61
| – | – | ﹤0.01% | 791 |
|
2024
Q3 | $4.75K | Hold |
61
| – | – | ﹤0.01% | 747 |
|
2024
Q2 | $4.76K | Hold |
61
| – | – | ﹤0.01% | 721 |
|
2024
Q1 | $4.13K | Hold |
61
| – | – | ﹤0.01% | 755 |
|
2023
Q4 | $4.11K | Hold |
61
| – | – | ﹤0.01% | 712 |
|
2023
Q3 | $4.13K | Hold |
61
| – | – | ﹤0.01% | 690 |
|
2023
Q2 | $4.37K | Sell |
61
-1,396
| -96% | -$99.9K | ﹤0.01% | 699 |
|
2023
Q1 | $101K | Hold |
1,457
| – | – | 0.02% | 157 |
|
2022
Q4 | $98.8K | Hold |
1,457
| – | – | 0.03% | 151 |
|
2022
Q3 | $80K | Hold |
1,457
| – | – | 0.02% | 177 |
|
2022
Q2 | $96K | Hold |
1,457
| – | – | 0.03% | 139 |
|
2022
Q1 | $97K | Hold |
1,457
| – | – | 0.03% | 145 |
|
2021
Q4 | $85K | Hold |
1,457
| – | – | 0.02% | 169 |
|
2021
Q3 | $88K | Buy |
1,457
+1,169
| +406% | +$70.6K | 0.03% | 155 |
|
2021
Q2 | $17K | Hold |
288
| – | – | 0.01% | 418 |
|
2021
Q1 | $14K | Hold |
288
| – | – | ﹤0.01% | 411 |
|
2020
Q4 | $14K | Hold |
288
| – | – | 0.01% | 354 |
|
2020
Q3 | $16K | Hold |
288
| – | – | 0.01% | 296 |
|
2020
Q2 | $15K | Buy |
288
+61
| +27% | +$3.18K | 0.01% | 283 |
|
2020
Q1 | $10K | Hold |
227
| – | – | 0.01% | 302 |
|
2019
Q4 | $11K | Hold |
227
| – | – | 0.01% | 345 |
|
2019
Q3 | $10K | Hold |
227
| – | – | 0.01% | 336 |
|
2019
Q2 | $9K | Hold |
227
| – | – | 0.01% | 350 |
|
2019
Q1 | $9K | Buy |
+227
| New | +$9K | 0.01% | 350 |
|